14-day Premium Trial Subscription Try For FreeTry Free
$0.0670
+0 (+0%)
At Close: Jun 17, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions Profile
There is currently no insider trading information for this ticker.

However, we invite you to learn more about this term and how to use this knowledge to benefit your trading strategy:
Click to get the best stock tips daily for free!

About Noxopharm Limited

Noxopharm Limited Noxopharm Limited, a drug development company, engages in the research and development of drugs for the treatment of cancer and prevention of septic shock in Australia and internationally. It primarily develops Veyonda, which is an adjuvant therapy in chemotherapy and radiotherapy for the treatment of late-stage cancers. The company also develops DARRT program that is in Phase 1b/2a for the treatment of metastatic castration-resistant prostate ca... NOX.AX Profile

Golden Star

Ticker Date Change Price
LIN Jun 12 0.640% $434.17
BNDX Jun 12 0.637% $48.64
MAIN Jun 12 0.673% $49.01
EQR Jun 11 1.77% $65.55
RPM Jun 11 0.92% $110.28
FR Jun 11 1.52% $46.78
CAH Jun 11 1.20% $99.01
ESI Jun 11 11.50% $23.73
FTGC Jun 11 0.374% $24.09
FTSM Jun 11 0.0838% $59.68
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT